24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
NaNose Medical,
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:46
High-tech entrepreneur Moshe Yanai’s debts balloon to $250 million
21:24
"A Robin Hood movement to help the smaller developers": How Appcharge is fighting app store monopolies
17:13
Full list of Israeli high-tech funding rounds in 2026
17:09
Israeli startup bets on psychedelic mushrooms for mental health treatment
More stories
Buzz
Most popular
Daily
Weekly
1
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
2
The 50 most promising Israeli startups - 2026
3
Five bidders advance in Nice’s $2.5 billion Actimize sale process
4
“Israel will remain a cyber powerhouse for the next decade”
5
SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread
More news
NaNose Medical,
2 stories about NaNose Medical,
“We want to be in every clinic”: The Israeli startup out to change early disease detection
09.06.25
|
Amy Shapiro
Backed by Google, the EU, and the IIA, NaNose Medical is pioneering non-invasive, breath-based diagnostics to close the gap in early detection of liver and lung cancer. As it approaches its Series A, co-founder and COO Ilay Marom says the Israeli startup is already eyeing real-world deployment and commercialization.
"Running a startup is like going to war—you need teammates who don’t give up when things get hard"
13.05.25
|
Hagai Gilboa
Ilay Marom, co-founder and COO of the startup NaNose Medical, was speaking on a panel held at Google and Calcalist’s Startup Week. Yair Levy, Brain.space: "I think Israel—its people and its tech ecosystem—has proven its resilience and creativity."